Novartis could expand direct-to-patient sales in US, CEO says

Go back to Novartis could expand direct-to-patient sales in US, CEO says
NOVARTIS AG (NYSE: NVS) Delayed: 142.71 --0 (-0%)
Previous Close $142.71    52 Week High $89.15 
Open $142.71    52 Week Low $69.84 
Day High $142.71    P/E N/A 
Day Low $142.71    EPS $0.00 
Volume 11,926